AKT1 and metabolic dysfunction-associated steatotic liver disease: As is shown in Figure 3G, H, I, J and K, aucubin could enhance the phosphorylation of ACC, AMPKα, AMPKβ and AKT significantly on tyloxapol‐induced NAFLD of mice.